Dennis H. Oh, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Dennis H. Oh, MD, PhD

Assistant Professor in Residence, Department of Dermatology, UCSF

ohd@derm.ucsf.edu

Phone: (415) 750-2091 (voice)
4150 Clement Street, VAMC 190, San Francisco, CA 94121

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Non-aligned

Education

Stanford University, Stanford, CA, B.S. June 1985, Chemistry (w/ Honors), Biological Sciences
Stanford University, Stanford, CA, Ph.D., June 1991, Biophysics
Stanford University, Stanford, CA, M.D., June 1993, Medicine


Professional Experience

  • 1985-1993
    Trainee, Medical Scientist Training Program (MSTP), Stanford University School of Medicine
  • 1987-1991
    Graduate student, Biophysics Program, Stanford University
  • 1993-1994
    Internship, Department of Medicine, Brigham and Women's Hospital Clinical Fellow in Medicine, Harvard Medical School
  • 1994-1998
    Residency, Department of Dermatology, Stanford University School of Medicine
  • 1996-2000
    Postdoctoral fellow, Department of Dermatology and Biological Sciences, Stanford University
  • 1998-2000
    Clinical Instructor, Department of Dermatology, Stanford University School of Medicine
  • 7/00-10/00
    Assistant Adjunct Professor, Department of Dermatology, University of California, San Francisco
  • 7/00-present
    Assistant Chief of Dermatology, San Francisco VA Medical Center
  • 10/00-present
    Assistant Professor in Residence, Department of Dermatology, University of California, San Francisco
  • 1/1/01-7/1/01
    Acting Chief of Dermatology, San Francisco VA Medical Center

Honors & Awards

  • 1983
    American Heart Association Summer Student Research Internship, Lawrence Berkeley Laboratory, University of California at Berkeley
  • 1983, 1984
    Korean Honor Scholarship, Republic of Korea
  • 1985
    Graduation with Honors (Chemistry) and with Distinction, Stanford University
  • 1985
    Firestone Medal for Excellence in Research, Stanford University
  • 1985
    Phi Beta Kappa, Stanford University
  • 1985
    Phi Lambda Upsilon (Chemistry), Stanford University
  • 1985-1992
    National Research Service Award (Medical Scientist Training Program, Stanford University Medical School)
  • 1996-1997
    Bank of America-Giannini Foundation Medical Research Fellow
  • 1996-1997
    Cancer Research Foundation of America Fellowship
  • 1997-2002
    Mentored Clinical Scientist Development Award (K08)
  • 2001-2002
    Dermatology Foundation Research Grant
  • 2001-2002
    U.C. San Francisco REAC Award
  • 2002-2005
    VA Merit Review Entry Program Award

Selected Publications

  1. Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A. Br J Dermatol. 2015 Sep; 173(3):751-9.
    View on PubMed
  2. Teledermatology Within the Veterans Health Administration, 2002-2014. Telemed J E Health. 2015 Oct; 21(10):769-73.
    View on PubMed
  3. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 2014 Nov 20; 9(4):1228-34.
    View on PubMed
  4. Vitamin D in cutaneous carcinogenesis: part I. J Am Acad Dermatol. 2012 Nov; 67(5):803.e1-12, quiz 815-6.
    View on PubMed
  5. Vitamin D in cutaneous carcinogenesis: part II. J Am Acad Dermatol. 2012 Nov; 67(5):817.e1-11; quiz 827-8.
    View on PubMed
  6. Protective role of vitamin D signaling in skin cancer formation. J Steroid Biochem Mol Biol. 2013 Jul; 136:271-9.
    View on PubMed
  7. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome. J Cutan Pathol. 2012 Oct; 39(10):911-7.
    View on PubMed
  8. Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int J Cancer. 2012 Oct 15; 131(8):1818-27.
    View on PubMed
  9. Vitamin D receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. J Invest Dermatol. 2012 Aug; 132(8):2097-100.
    View on PubMed
  10. State of teledermatology programs in the United States. J Am Acad Dermatol. 2012 Nov; 67(5):939-44.
    View on PubMed
  11. Targeting protein-trafficking pathways alters melanoma treatment sensitivity. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):553-8.
    View on PubMed
  12. Functional relevance of the histone gammaH2Ax in the response to DNA damaging agents. Proc Natl Acad Sci U S A. 2011 May 24; 108(21):8663-7.
    View on PubMed
  13. Structural determinants of photoreactivity of triplex forming oligonucleotides conjugated to psoralens. J Nucleic Acids. 2010; 2010.
    View on PubMed
  14. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas. Am J Pathol. 2010 Aug; 177(2):555-62.
    View on PubMed
  15. Hereditary photodermatoses. Adv Exp Med Biol. 2010; 685:95-105.
    View on PubMed
  16. Basal cell carcinomas arising within multiple trichoepitheliomas. J Cutan Pathol. 2008 Oct; 35 Suppl 1:59-64.
    View on PubMed
  17. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol. 2008 Aug; 59(2):260-7.
    View on PubMed
  18. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide. Photochem Photobiol. 2008 May-Jun; 84(3):727-33.
    View on PubMed
  19. American Telemedicine Association's Practice Guidelines for Teledermatology. Telemed J E Health. 2008 Apr; 14(3):289-302.
    View on PubMed
  20. DNA polymerase eta reduces the gamma-H2AX response to psoralen interstrand crosslinks in human cells. Exp Cell Res. 2008 Feb 15; 314(4):887-95.
    View on PubMed

Go to UCSF Profiles, powered by CTSI